María J. Gutiérrez

Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol

Evan A. Stein, Scott Mellis, George D. Yancopoulos et al. · New England Journal of Medicine · 2012 · 659 citations · Full text

Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies

Rajesh Krishna, Matt S. Anderson, Arthur Bergman et al. · The Lancet · 2007 · 276 citations

Metabolic Syndrome, Hypertension, Healthy Individuals +10

Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Sodium Glucose Co‐Transporter 2 Inhibitor, in Subjects With Type 2 Diabetes Mellitus

Damayanthi Devineni, Christopher R. Curtin, David Polidori et al. · The Journal of Clinical Pharmacology · 2013 · 211 citations

Progesterone/RANKL Is a Major Regulatory Axis in the Human Breast

Tamara Tanos, George Sflomos, Pablo C. Echeverría et al. · Science Translational Medicine · 2013 · 210 citations · Full text

Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: A randomized, double-blind, placebo-controlled study

Desmond Padhi, Mark Allison, Alan Kivitz et al. · The Journal of Clinical Pharmacology · 2013 · 182 citations · Full text

Sclerostin, Immunology, Pharmacotherapy +17